193 related articles for article (PubMed ID: 10749870)
1. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque.
Shirk RA; Parthasarathy N; San Antonio JD; Church FC; Wagner WD
J Biol Chem; 2000 Jun; 275(24):18085-92. PubMed ID: 10749870
[TBL] [Abstract][Full Text] [Related]
2. Interaction of heparin cofactor II with biglycan and decorin.
Whinna HC; Choi HU; Rosenberg LC; Church FC
J Biol Chem; 1993 Feb; 268(6):3920-4. PubMed ID: 8440685
[TBL] [Abstract][Full Text] [Related]
3. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone MM; Tollefsen DM
J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
[TBL] [Abstract][Full Text] [Related]
4. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
Shirk RA; Church FC; Wagner WD
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extracellular matrix at low cell density.
Fujiwara Y; Tsumura N; Yamamoto C; Kaji T
Toxicology; 2002 Jan; 170(1-2):89-101. PubMed ID: 11750086
[TBL] [Abstract][Full Text] [Related]
7. The interaction of glycosaminoglycans with heparin cofactor II.
Tollefsen DM
Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
[TBL] [Abstract][Full Text] [Related]
8. Immortalized, cloned mouse chondrocytic cells (MC615) produce three different matrix proteoglycans with core-protein-specific chondroitin/dermatan sulphate structures.
Kokenyesi R; Silbert JE
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):831-9. PubMed ID: 9581563
[TBL] [Abstract][Full Text] [Related]
9. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
10. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
11. Distinct isoforms of chicken decorin contain either one or two dermatan sulfate chains.
Blaschke UK; Hedbom E; Bruckner P
J Biol Chem; 1996 Nov; 271(48):30347-53. PubMed ID: 8939995
[TBL] [Abstract][Full Text] [Related]
12. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
13. Patterns of uronosyl epimerization and 4-/6-O-sulphation in chondroitin/dermatan sulphate from decorin and biglycan of various bovine tissues.
Cheng F; Heinegård D; Malmström A; Schmidtchen A; Yoshida K; Fransson LA
Glycobiology; 1994 Oct; 4(5):685-96. PubMed ID: 7881183
[TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA; Tollefsen DM
J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
[TBL] [Abstract][Full Text] [Related]
15. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
16. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
17. Molecular mapping of the thrombin-heparin cofactor II complex.
Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
[TBL] [Abstract][Full Text] [Related]
18. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
19. Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment.
Lee PH; Trowbridge JM; Taylor KR; Morhenn VB; Gallo RL
J Biol Chem; 2004 Nov; 279(47):48640-6. PubMed ID: 15347686
[TBL] [Abstract][Full Text] [Related]
20. WISP-1 binds to decorin and biglycan.
Desnoyers L; Arnott D; Pennica D
J Biol Chem; 2001 Dec; 276(50):47599-607. PubMed ID: 11598131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
